title: Laboratory tests for evaluating the level of attenuation of bluetongue virus.
abstract: One of the most important steps when preparing a live attenuated vaccine is the assessment of the level of attenuation in target animals. It is costly and time consuming as it requires, on each occasion, a large number of susceptible animals and contained accommodation. This study assessed the consistency of the bovine foetal aorta endothelial (BFA) cell line and newborn mice for evaluating the attenuation level of BTV4, BTV9 and BTV16 Italian field isolates. Following serial passages in BHK(21c13) or Vero cell cultures, BTV attenuated clones demonstrated a reduced replication capability in the BFA cells compared to the homologous virulent strains. Similarly, following intracerebral inoculation, the attenuated clones were completely innocuous to newborn mice contrary to the homologous virulent strains which killed all animals within 10 days. Vaccines produced with the BTV9 or BTV4 attenuated clones were safe, immunogenic and capable of preventing clinical symptoms and viraemia in sheep following challenge with homologous virulent virus. The two assays may be valuable indicators of the gradual changes occurring in the BTV population leading to virus attenuation, they can predict the safety of a BTV attenuated vaccine and, in turn, reduce the number of sheep and cattle required to assess the level of attenuation attained.
authors.affiliation: Istituto Zooprofilattico Sperimentale dell'Abruzzo e del Molise G. Caporale, Via Campo Boario, 64100 Teramo, Italy.
authors.forename: P
authors.initials: P
authors.lastname: Franchi
authors.forename: M T
authors.initials: MT
authors.lastname: Mercante
authors.forename: G F
authors.initials: GF
authors.lastname: Ronchi
authors.forename: G
authors.initials: G
authors.lastname: Armillotta
authors.forename: S
authors.initials: S
authors.lastname: Ulisse
authors.forename: U
authors.initials: U
authors.lastname: Molini
authors.forename: M
authors.initials: M
authors.lastname: Di Ventura
authors.forename: R
authors.initials: R
authors.lastname: Lelli
authors.forename: G
authors.initials: G
authors.lastname: Savini
authors.forename: A
authors.initials: A
authors.lastname: Pini
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D001011:Aorta / Q000166:cytology; D001819:Bluetongue / Q000401:mortality / Q000517:prevention & control* / Q000821:virology; D001820:Bluetongue virus / Q000472:pathogenicity* / Q000502:physiology; D002460:Cell Line; D002522:Chlorocebus aethiops; D006224:Cricetinae; D004622:Embryo, Mammalian; D042783:Endothelial Cells / Q000821:virology*; D051379:Mice; D012756:Sheep; D012757:Sheep Diseases / Q000401:mortality / Q000517:prevention & control / Q000821:virology; D014613:Vaccines, Attenuated / Q000008:administration & dosage; D014709:Vero Cells; D014765:Viral Vaccines / Q000008:administration & dosage; D014774:Virulence; D014779:Virus Replication
chemical_list: D014613:Vaccines, Attenuated; D014765:Viral Vaccines